Project Grant K99NS146612
- Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded the University of California, Davis a $457,714 Project Grant on July 15, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The award funds fundamental neuroscience research investigating post-transcriptional regulatory mechanisms governing cortical cell fate specification in the developing brain. The research will employ advanced molecular...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $521,839 to the University of California, San Diego on August 7, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. This five-year project grant, scheduled for completion by July 31, 2030, supports fundamental research investigating the mechanisms of pathogenic microglial populations in central nervous system (CNS)...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $438,625 Project Grant to the University of California, San Diego on August 7, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The research initiative, extending through July 31, 2027, investigates a novel neuroprotective mechanism against ischemic brain injury by characterizing "actinification"—a pro-survival...
- Federal Grant Award Summary The J. David Gladstone Institutes received a Project Grant award of $1.38 million from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective September 1, 2025, through August 31, 2033. This eight-year research initiative focuses on understanding neurovascular interactions and their role in central nervous system (CNS) diseases...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $1,180,687 to The Regents of the University of California, San Francisco under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective August 1, 2025, with a completion date of July 31, 2033. This eight-year Project Grant supports fundamental research investigating the developmental transition of neural stem cell (NSC) niches in...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Regents of the University of California, San Francisco $654,593 under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program on August 15, 2025. This five-year project grant, extending through July 31, 2030, funds research to elucidate the molecular mechanisms by which mutations in blood-brain barrier (BBB) choline transporters—specifically...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $427,625 Project Grant to the University of Maryland, Baltimore on July 17, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The grant funds research to develop a toolbox for studying proteome plasticity in brain endothelial cells, with a project completion date of June 30, 2027. The research addresses fundamental...
- Federal Grant Award Summary The Salk Institute for Biological Studies received a $150,104 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award, effective February 1, 2026, through October 31, 2028, supports research to develop advanced in vitro methods for growing brain organoids with improved structural complexity, cellular diversity,...
- This $437,250 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program will support research to compare the gene expression of the key cell types that form the blood-nerve barrier (BNB) in the peripheral nervous system and the blood-brain barrier (BBB) in the central nervous system under physiological conditions. The research will also...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $489,197 in Project Grant funding (CFDA 93.853: Extramural Research Programs in the Neurosciences and Neurological Disorders) to the Research Foundation For Mental Hygiene, Inc., a nonprofit research organization affiliated with the New York State Psychiatric Institute, for the period July 1, 2025 through June 30, 2030. This five-year award supports fundamental neuroscience research...
This Project Grant award of $121,554.00 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) was granted on February 3, 2026, with a completion date of January 31, 2028. The award supports investigator-initiated research conducted at the University of California, San Diego to investigate the molecular and cellular mechanisms underlying tanycyte barrier formation and function at the median eminence, a specialized brain region critical to neuroendocrine regulation. The research will examine the role of claudin-10, a key tight junction protein, in maintaining barrier integrity and regulating ion permeability, as well as how systemic and central nervous system inflammation disrupts tanycyte-mediated barrier function. The expected deliverables from this two-year research initiative include scientific findings that advance understanding of circumventricular organ barriers, their distinct functional characteristics compared to other blood-brain barrier regions, and their response to inflammatory conditions. The project aims to provide critical insights into the dynamics of central nervous system barriers and their impact on neuroinflammatory and metabolic disorders, with potential applications for developing therapeutic interventions to address these conditions. The research contributes to NINDS's mission to reduce the burden of neurological disease through fundamental knowledge generation about brain and nervous system function.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $121.6k | 2/2/26 |